Back to search results

A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder

Abroad (travel likely)RecruitingPHASE2

Conditions

Bipolar I Disorder · Bipolar II Disorder

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • University of Alabama - Huntsville Regional Medical Campus /ID# 272951, Huntsville, Alabama, United States

  • Chandler Clinical Research Trials /ID# 274500, Chandler, Arizona, United States

  • Del Sol Research Management - East Tanque Verde Road - Tucson /ID# 279767, Tucson, Arizona, United States

  • Sanro Clinical Research Group /ID# 279462, Bryant, Arkansas, United States

  • Advanced Research Center /ID# 272828, Anaheim, California, United States

  • Collaborative Neuroscience Research - Garden Grove /ID# 271917, Garden Grove, California, United States

  • Catalina Research Institute /ID# 272831, Montclair, California, United States

  • Excell Research /ID# 272854, Oceanside, California, United States

  • Pacific Neuropsychiatric Specialists - Orange /ID# 273118, Orange, California, United States

  • Schuster Medical Research Institute /ID# 272848, Sherman Oaks, California, United States

  • Sarkis Clinical Trials- Gainesville /ID# 272861, Gainesville, Florida, United States

  • CenExel Hollywood FL /ID# 273101, Hollywood, Florida, United States

  • Accel Research Sites Network - St. Pete /ID# 272962, Largo, Florida, United States

  • Apg Research /ID# 272925, Orlando, Florida, United States

  • Combined Research Orlando /ID# 279458, Orlando, Florida, United States

  • Clinical Research Center Of Florida /ID# 278790, Pompano Beach, Florida, United States

  • St. Johns Center for Clinical Research - Saint Augustine Location /ID# 279465, Saint Augustine, Florida, United States

  • Neuroscience Institute - West Palm Beach /ID# 272922, West Palm Beach, Florida, United States

  • Georgia Psychiatric Consultants and Advanced Discovery Research /ID# 279438, Atlanta, Georgia, United States

  • Pillar Clinical Research - Chicago /ID# 272823, Chicago, Illinois, United States

    Study coordinator · 2245347332

  • Amr Conventions Research /ID# 272867, Warrenville, Illinois, United States

  • Saint Charles Psychiatric Associates /ID# 279239, Saint Charles, Missouri, United States

  • Manhattan Behavioral Medicine /ID# 279769, New York, New York, United States

  • University Of Cincinnati Medical Center /ID# 274160, Cincinnati, Ohio, United States

  • The Ohio State University /ID# 272954, Columbus, Ohio, United States

  • Sooner Clinical Research /ID# 272856, Oklahoma City, Oklahoma, United States

  • Community Clinical Research - Cross Park Drive /ID# 272940, Austin, Texas, United States

  • Elixia - Houston /ID# 279200, Houston, Texas, United States

  • Mind Matters Psychiatry /ID# 273536, Missouri City, Texas, United States

  • Pillar Clinical Research - Richardson /ID# 272821, Richardson, Texas, United States

  • Family Psychiatry Of The Woodlands /ID# 275177, The Woodlands, Texas, United States

  • Northwest Clinical Research Center /ID# 272847, Bellevue, Washington, United States

  • Core Clinical Research /ID# 272955, Everett, Washington, United States

Study leads

  • ABBVIE INC.

    Study Director

    AbbVie

View source on ClinicalTrials.gov(opens in a new tab)